<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Actiq News</title>
<link>http://www.inboxrobot.com/news/actiq</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Cephalon pleads to crime in off-label drug sales</title>
<link>http://www.inboxrobot.com/news.php?fid=192502112</link>
<pubDate>10 Oct 2008 17:29 GMT</pubDate>
<description>
... Cephalon pleads to crime in off-label drug sales Drugmaker Cephalon has pleaded guilty in  ...  prosecutors say Cephalon marketed off-label uses to doctors, contributing to sharply increased sales. The drugs  ...  sharply increased sales. The drugs involved are Actiq, a highly addictive lollipop painkiller, the anti-epilepsy  ...
</description>
</item><item>
<title>Ohio Sales Rep&apos;s Information Launched Massive Government Investigation of Cephalon</title>
<link>http://www.inboxrobot.com/news.php?fid=192388427</link>
<pubDate>10 Oct 2008 01:37 GMT</pubDate>
<description>
...  $425,000,000 settlement and guilty plea by the pharmaceutical company began in January 2003 with a  ...  strategies to convince doctors to prescribe Cephalon&apos;s Actiq, Gabitril and Provigil drugs for unapproved (&quot;off-label&apos;) uses because he was  ...
</description>
</item><item>
<title>Biopharmaceutical Company, Cephalon, To Pay $425 Million &amp; Enter Plea to Resolve Allegations of Off-Label Marketing</title>
<link>http://www.inboxrobot.com/news.php?fid=192388426</link>
<pubDate>10 Oct 2008 01:37 GMT</pubDate>
<description>
... Biopharmaceutical Company, Cephalon, To Pay $425 Million &amp;  ...  to resolve claims that it marketed three drugs for uses not approved by the Food  ...  engaged in a scheme to market Gabitril, Actiq and Provigil for unapproved uses in violation  ...
</description>
</item></channel>
</rss>
